ArticleCancer immunology, immunotherapy : CII2013

Elotuzumab directly enhances NK cell cytotoxicity against myeloma via CS1 ligation: evidence for augmented NK cell function complementing ADCC.

Shauna M Collins et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.